Since little information is available regarding cellular antigen mapping and the involvement of nonneuronal cells in the pathogenesis of bovine herpesvirus type 5 (BHV-5) infection, it were determined the BHV-5 distribution, the astrocytic reactivity, the involvement of lymphocytes and the presence of matrix metalloproteinase (MMP)-9 in the brain of rabbits experimentally infected with BHV-5. Twelve New Zealand rabbits that were seronegative for BHV-5 were used for virus inoculation, and five rabbits were used as mock-infected controls. The rabbits were kept in separate areas and were inoculated intranasally with 500 ml of virus suspension (EVI 88 Brazilian isolate) into each nostril (virus titer, 10 7.5 TCID50). Control rabbits were inoculated with the same volume of minimum essential medium. Five days before virus inoculation, the rabbits were submitted to daily administration of dexamethasone. After virus inoculation, the rabbits were monitored clinically on a daily basis. Seven rabbits showed respiratory symptoms and four animals exhibited neurological symptoms. Tissue sections were collected for histological examination and immunohistochemistry to examine BHV-5 antigens, astrocytes, T and B lymphocytes and MMP-9. By means of immunohistochemical and PCR methods, BHV-5 was detected in the entire brain of the animals which presented with neurological symptoms, especially in the trigeminal ganglion and cerebral cortices. Furthermore, BHV-5 antigens were detected in neurons and/or other nonneural cells. In addition to the neurons, most infiltrating CD3 T lymphocytes observed in these areas were positive for MMP-9 and also for BHV-5 antigen. These infected cells might contribute to the spread of the virus to the rabbit brain along the trigeminal ganglia and olfactory nerve pathways.
Introduction
Bovine herpesvirus type 5 (BHV-5), a member of the family Alphaherpesvirinae, is a major etiological agent of meningoencephalitis in cattle [1, 2] . The disease has been characterized by tremors, nystagmus, tooth grinding, circling, ataxia, recumbence, paddling, and death [3, 4] . Following replication in the nasal mucosa, BHV-5 invasion into the brain is thought to occur mainly through the olfactory pathway and sensory neurons of the trigeminal ganglion (TG) [5] .
Acute BHV-5 infection and disease have been successfully reproduced in rabbits [6e9] and sheep [10] . These experimental models have been used for biological studies to understand the molecular basis of BHV-5 acute and latent infection [11, 12] .
In contrast to many other animal herpesvirus infections, BHV-5 reactivation is frequently accompanied by a recrudescence of clinical disease, both in the natural host and in a rabbit model. In animals surviving after acute infection, BHV-5 establishes a lifelong latent infection that can be reactivated under certain natural or induced stimuli [4, 11] .
Lesions related to central nervous system (CNS) infection have been well-described in cattle [4] , rabbits [7, 9] and sheep [10] ; these descriptions have primarily focused on aspects of neuronal degeneration and inflammatory response. The distribution of BHV-5 DNA during the acute and latent phases of infection in experimentally infected rabbits and calves has already been determined [12, 13] .
In rabbits, the trigeminal nerve and the olfactory pathway are important routes for BHV-5 access to the CNS [5, 14] . However, other pathways for BHV-5 spread must be considered, such as leukocytefacilitated entry across the cerebral barriers or via the choroid plexus and meninges [15, 16] . A key component for leukocyte migration is matrix metalloproteinase 9 (MMP-9, gelatinase B) because MMP-9 degrades type IV collagen, the primary component of the basal membrane [17, 18] .
Little information is available regarding cellular antigen mapping or the possible participation of non-neuronal cells in the pathogenesis of BHV-5 infection in rabbits or calves. Also, other cellular types that can serve as a virus keeper and transporter must be better established. Therefore, the purpose of this study was to examine BHV-5 distribution, astrocytic reactivity, involvement of the main populations of lymphocytes (T and B) and the presence of MMP-9 in several areas of the brain from rabbits experimentally infected with a Brazilian isolate of BHV-5.
Materials and methods

Animals
Seventeen New Zealand white male rabbits provided by the College of Veterinary Medicine and Animal Science e University of São Paulo (FMVZ-USP) that were seronegative for BHV-5, five to six weeks-old, and weighed 0.8e1.0 kg were used in this experiment. All rabbits were group-housed (three rabbits per cage). Before any experimental manipulation, the rabbits were allowed to acclimatize to laboratory conditions for one week. Food and water were provided ad libitum. Twelve rabbits were used for virus inoculation (infected group), and five animals were used as controls (control group).
Virus, BHV-5 intranasal infection and dexamethasone treatment
The Brazilian BHV-5 isolate EVI-88 was obtained from Dr. Paulo M. Roehe (UFRGS -Rio Grande do Sul e Brazil). The virus that was used in all experiments was propagated and titrated in MadineDarby bovine kidney (MDBK) cells. Rabbits were anesthetized by intramuscular (i.m.) injection of ketamine (5 mg/kg) plus xylazine (35 mg/kg). The rabbits were inoculated intranasally with 10 7.5 TCID 50 (median tissue culture infectious dose; which is the amount of a pathogenic agent that will produce pathological change in 50% of cell cultures) of BHV-5 in 500 mL of minimum essential medium (MEM). Control rabbits were inoculated with the same volume of MEM. Five days before inoculation (b.i.), the rabbits were submitted to daily administration of dexamethasone (Dx; 0.5 mg/kg/ day, i.m.) in order to promote infection [7, 11, 12] . After Dx treatment and virus inoculation, the rabbits were monitored clinically on a daily basis for 23 days. Animals were sacrificed as they exhibited neurological symptoms and all the other rabbits were euthanized at day 23 post inoculation (p.i.).
Postmortem sampling
The rabbits were sacrificed, necropsies were performed, and macroscopic lesions were recorded. Each brain was removed and sagitally sliced; one hemisphere was fixed in 10% neutral buffered formalin and paraffin-embedded for histopathology and immunohistochemistry. The other hemisphere was frozen and stored at À80 C for DNA extraction and PCR.
Immunohistochemistry
For immunohistochemistry, endogenous peroxidase activity was blocked after dewaxing by incubating the sections in 2% (v/v) hydrogen peroxide (30 vol.) diluted in 50% (v/v) methanol for 30 min. Pre-treatments for antigen retrieval were performed according to the specifications for the primary antibodies (Table 1) . Non-specific binding was blocked with 3% (w/v) nonfat dry milk in PBS (phosphate-buffered saline) pH 7.2 for 30 min. The sections were incubated with the primary antibodies ( Table 1) for 18e22 h at 4 C in a humidified chamber. The slides were washed in PBS and incubated with a biotinylated secondary antibody and a streptavidin-HRP complex (LSABþ Kit, K0690, Dako) according to the manufacturer's instructions. The reaction was developed with 3,3 0 -diaminobenzidine (K3468, Dako). The slides were counterstained with Harris's hematoxylin, dehydrated, cleared, and mounted with coverslips. Negative control sections were prepared by replacing the primary antibody with 1% (v/v) bovine serum albumin (BSA). The tissue samples were examined by light microscopy in the following areas of the cerebral hemisphere: (1) cerebellum, (2) cerebral cortex (frontal, temporal, occipital, parietal and piriform), (3) hippocampus, (4) midbrain, (5) olfactory bulb, (6) pons-medulla oblongata, (7) sub-ependymal zone, (8) thalamus, and (9) trigeminal ganglion.
The intensity of glial fibrillary acidic protein (GFAP) labeling was scored semiquantitatively on a four-point scale of 1e4. A score of 1 represented mild GFAP labeling; a score of 2, moderate; 3, intense; and a score of 4 represented very intense GFAP labeling. The quantification of CD3 þ and CD79 þ cells was performed by counting the number of positive cells/mm 2 [19] in the pre-established brain areas. The evaluation of BHV-5 and MMP-9 labeling consisted of semiquantitative mapping according to the labeled cell and to the brain area. All analyses were "blind", i.e., the researchers were denied knowledge of the experimental groups.
DNA extraction and PCR
Fragments from seven different brain areas were obtained: (1) brainstem, (2) cerebellum, (3) frontal cortex and olfactory bulb, (4) temporal cortex, (5) parietal and piriform cortices, (6) midbrain and diencephalon, (7) trigeminal ganglion. The extraction of DNA was performed using proteinase K and phenol-chloroform. The primers forward (GD1: 5 0 -GCCCGCAGTTTCCCCTACC-3 0 ) and reverse (GD2: 5 0 -CGCACCCGCTCTCAATCTT-3 0 ) were designed to amplify one region of the viral glycoprotein D, resulting in an amplicon of 564 bp [20] . The PCR conditions were: 95 C for 3 min, followed by 40 cycles of 95 C for 45 seg, 61 C for 45 seg, and 72 C for 45 seg, and then 72 C for 10 min. The PCR products were analyzed on ethidium bromide-stained agarose gels.
Statistical analysis
For CD3 þ and CD79 þ cells, significant differences between groups were determined by one-way ANOVA followed by Tukey's Multiple Comparison Test. A value of P < 0.05 was considered statistically significant. Data are expressed as mean AE standard deviation (SD). All statistical analyses were performed using Prism software (GraphPad, California, USA).
Ethics
All animal handling procedures and experimentation were performed according to the recommendations of the Brazilian College on Animal Experimentation, and all experiments were approved by the institutional Ethics and Animal Welfare Committee (CEEA e Comissão de Ética e Experimentação Animal -UNESP, process #08/05).
Results
Clinical signs
Seven animals (rabbit identification numbers 4, 6, 7, 9, 12, 14, and 15) displayed nasal and ocular discharges from day 12 to day 23 p.i. Rectal temperatures were not notably different between infected and control rabbits. Neurological symptoms were observed only in rabbits 4, 6, 7, and 14, and they were characterized by slight apathy to depression, seizures and grinding of teeth. Because the remaining animals were euthanatized at day 23 p.i., whether neurological signs would have developed after this period is unknown.
Postmortem findings
Gross cerebral lesions were observed in 3 rabbits (numbers 6, 7, and 14). These lesions were composed of softening of the parenchymal tissue and hemorrhagic foci in the olfactory bulbs and frontal cortex. The lesions were not symmetrical and did not have a well-defined pattern of distribution. No macroscopic lesions were seen in the CNS of the control rabbits.
CNS histopathology
Microscopic examination revealed histological changes of varied severity in several areas of the brain, but mostly in the cerebral cortex (frontal, temporal, occipital, parietal and piriform) of rabbits that died or were sacrificed with neurological symptoms (rabbits 4, 6, 7, and 14). These changes were characterized by the presence of mononuclear perivascular cuffs, neuronophagia, satellitosis, focal and diffuse gliosis, congestion, hemorrhages, neuronal degeneration and necrosis. Non-suppurative leptomeningitis was present in 91.7% (11/12) of the animals in the olfactory bulb and frontal/ temporal cortex, but was less frequent in caudal encephalic areas, such as the pons, medulla oblongata and cerebellum. Inclusions bodies were not observed in neurons or astrocytes.
BHV-5 detection in the brain of rabbits
The infected rabbits that exhibited neurological symptoms (neurological, n ¼ 4) presented a different pattern of viral distribution in the brain than the infected rabbits without neurological involvement (non-neurological, n ¼ 8).
BHV-5 was detected by means of PCR in all infected rabbits. Regarding the viral distribution across the brain, BHV-5 could be detected in all the selected areas in the neurological rabbits. On the other hand, in the brains of the non-neurological rabbits, BHV-5 was detected in an inconstant manner (Fig. 1) .
In regards to BHV-5 antigen detected by means of IHC, the findings were similar to those seen with PCR. The viral antigen was detected principally in cortical neurons, but also in ependymal cells, endothelial cells, the hippocampus, diencephalon and midbrain. A small number of positive neurons were observed in the cerebellum and in the pons/medulla oblongata. Trigeminal ganglion cells and inflammatory mononuclear cells with positive staining were also detected (Fig. 2aef) . Whereas the BHV-5 antigen was detected all over the brains of neurological animals, the distribution of the virus in the brains of non-neurological animals was noted primarily in the cranial areas, periventricular regions and the olfactory and trigeminal tracts (Fig. 2g) .
Immunohistochemical evaluation of astrocyte alterations during BHV-5 infection in rabbits
Reactive astrocytes were observed, particularly in cortical areas, the hippocampus, and the subependymal layer; these reactive astrocytes were detected in the same locations as the viral antigen in the neurons of some of the animals (Fig. 3) . Astrocytosis, gemistocytic astrocytes and astrogliosis were also observed. Alterations in astrocyte morphology were more intense within the inflamed areas, and the astrocytes tended to present few numbers of processes, thickening of the processes, loss of processes, and large swollen nuclei. In the infected group, an increase in GFAP labeling was observed in the cerebral cortices, the hippocampus and the thalamus.
Immunohistochemical analysis of lymphocytes and MMP-9 in the brain of rabbits upon BHV-5 infection
Inflammatory infiltrates constituted by CD3
þ T lymphocytes were detected in all of the pre-established encephalic areas of the infected rabbits, including the perivascular cuffs, leptomeninges and in areas of malacia. A strong association between CD3 þ T lymphocytes and BHV-5 was detected since the CD3 þ cells were also positive for BHV-5 antigen (Fig. 4) (Fig. 5) . MMP-9 staining was observed diffusely in the neuropil and in different cells within the brain of the infected rabbits, such as neurons, astrocytes, and endothelial cells, but it was particularly present in the mononuclear cells of the inflammatory infiltrates, especially in the leptomeninges and in parenchymal perivascular cuffs. Furthermore, the pattern of MMP-9 labeling was very similar to that of the CD3 þ cells; in these cases, MMP-9 labeling was positive in the CD3 þ cells and in the extracellular area adjacent to these cells (Fig. 4) .
Discussion
Rabbit models have been used to address some questions concerning the immunopathogenesis of BHV-5 infection. Although this model has provided important information regarding some aspects of virus infectivity and pathogenesis, the participation of blood-derived immune cells and glial cells during this viral meningoencephalitis model must still be fully elucidated. Herpesvirus reactivation usually occurs in the absence of obvious clinical signals because a reduced number of neurons are involved and virus production is limited during reactivation [21] .
The p.i. onset of clinical signs in the rabbits was rather divergent from the times related in the literature. Differences in the time of respiratory and neurological signs presented after inoculation observed by Chowdhury et al. [7] and Silva et al. [9] may be related with the age of animals and/or inoculation method. Furthermore, Chowdhury et al. [7] used a different viral strain, which can result in different response to infection as observed by Silva et al. [9] with the Argentinean isolate A663.
Arachnoid lymphocytic infiltrate (leptomeningitis) was observed in an elevated percentage of encephalons, even in asymptomatic rabbits, indicating the involvement of lymphocytes in the pathogenesis of BHV-5 infection. One of the most distinctive viral encephalitis lesions, the perivascular cuffs, was most apparent in the symptomatic rabbits. The presence of lymphocytic leptomeningitis and/or perivascular cuffs demonstrated the progression of sub-acute to acute inflammatory changes in the brain and was well-correlated with BHV-5 antigen detection. Similar lesions have previously been demonstrated in acutely infected rabbits [7, 9, 22] and calves [4] .
Trigeminal ganglionitis has been described relatively early in calves [4] and less frequently in rabbits [9] . We observed inflammatory cells in the trigeminal ganglion in only three rabbits (25%), while antigen detection by immunohistochemistry occurred in 58.3% (7/12) of infected animals.
The intranasal route of infection directly introduces a neurotropic virus to a mucosal surface with distinct neuronal pathways to the CNS. In this study, we demonstrated through immunohistochemistry that the antigen was distributed over the entire brain of the rabbits after BHV-5 infection. In rabbits with neurological symptoms, the viral antigen was detected mostly in the hippocampus, parietal/occipital cortex, diencephalon, piriform cortex and midbrain, in accordance with the results found with PCR. The pattern of BHV-5 immunoreactivity supports the idea that following infection of the olfactory bulb glomeruli, the virus spreads via both ventricular surfaces and by retrograde transport within axons through structures indirectly connected to the olfactory pathway [22] . We verified that viral dissemination was compatible with the description of inflammatory/degenerative observed lesions. Most ischemic ("dark") neurons observed by HE exhibited positive staining for the BHV-5 antigen on serial sections. We did not detect the viral antigen in astrocytes, even though these cells showed remarkable changes in their morphology and areas of astrogliosis were detected where BHV-5 was observed.
In general, latency and reactivation are considered critical strategies for herpesviruses to survive in nature [23] . The major sites of latent infection in human (i.e., herpes simplex virus type 1 e HSV- The administration of corticosteroids is used in the BHV-5 infection model to mimic stress conditions and latent infection reactivation [7, 11] . Corticosteroids also may facilitate BHV-5 replication inside lymphocytes, since in a study with BHV-1, the authors detected no differences in lymphocytes population comparing latently infected calves and calves treated with dexamethasone, and concluded that CD4 þ T lymphocytes can be infected by BHV-1 [27] . Furthermore, despite the spread of the virus through the trigeminal ganglion and the olfactory bulb, infected leukocytes may contribute to viral dissemination into the rabbit brain. We detected BHV-5 positive CD3 þ T lymphocytes, suggesting that these cells can harbor the virus and facilitate their dissemination across the cerebral barriers. Not uncommonly, some a-herpesviruses infect and replicate in peripheral blood mononuclear cells, including BHV-1, PRV and equine herpesvirus type 1 (EHV-1) [28e31]. In addition, BHV-1 DNA has also been detected in CD4 þ T lymphocytes in the tonsils [27, 32] . In further support of the premise that leukocytes facilitate the entry of BHV-5 into the CNS, we also detected the presence of MMP-9 in the inflammatory infiltrates that were composed of primarily CD3
þ T lymphocytes. The involvement of MMP-9 has already been correlated with the pathogenesis of other herpesviruses infection, such as EpsteineBarr virus (EBV) and HSV-1 [33, 34] . Since MMPs, especially MMP-2 and MMP-9, are key to leukocyte influx into the brain [35] , this study provides evidences of BHV-5-infected T lymphocytes migration into the nervous milieu. Further, despite the anti-inflammatory effects that dexamethasone presents in the brain [36, 37] , the treatment with this drug in our model seems not to have influenced MMP-9 production by T lymphocytes, as previously described [38] .
In conclusion, these results provide important contributions to the understanding of BHV-5 neuropathogenesis in a rabbit model. The data presented herein suggest a new additional pathway for CNS invasion, in which BHV-5 spread is mediated by infected leukocytes. T lymphocytes, astrocytes and MMP-9 clearly play roles in the pathogenesis of BHV-5 infection. Nevertheless, further studies are needed to confirm the CNS invasion pathways and to identify other cells and molecules involved in this process. 
